Due to the highly specific nuclear expression pattern in normal and malignant cells of the gastrointestinal tract, SATB2 protein expression was suggested as a clinically useful diagnostic biomarker for colorectal cancers, the third most commonly diagnosed cancer in the world [10]. This evidence concerns the gene SATB2 and colorectal cancer.